Pérez, María José <br/><br/>
Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jun 2003 
 - 1395-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1053/jhep.2003.50228  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antioxidants--pharmacology<br/>Arachidonic Acid--poisoning<br/>Buthionine Sulfoximine--poisoning<br/>Carcinoma, Hepatocellular--pathology<br/>Cysteine Endopeptidases--physiology<br/>Cytochrome P-450 CYP2E1--metabolism<br/>Drug Synergism<br/>Endopeptidases--metabolism<br/>Humans<br/>Iron--poisoning<br/>Leupeptins--pharmacology<br/>Lipid Peroxides--metabolism<br/>Liver Neoplasms--pathology<br/>Lysosomes--enzymology<br/>Membrane Potentials--drug effects<br/>Mitochondria, Liver--physiology<br/>Multienzyme Complexes--antagonists & inhibitors<br/>Proteasome Endopeptidase Complex<br/>Tumor Cells, Cultured<br/>Tyrosine--analogs & derivatives